Artículos de revistas sobre el tema "NF-kappa B pathway"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "NF-kappa B pathway".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Johns, L. D., T. Sarr y G. E. Ranges. "Inhibition of ceramide pathway does not affect ability of TNF-alpha to activate nuclear factor-kappa B." Journal of Immunology 152, n.º 12 (15 de junio de 1994): 5877–82. http://dx.doi.org/10.4049/jimmunol.152.12.5877.
Texto completoOtieno, M. A. y M. W. Anders. "Cysteine S-conjugates activate transcription factor NF-kappa B in cultured renal epithelial cells". American Journal of Physiology-Renal Physiology 273, n.º 1 (1 de julio de 1997): F136—F143. http://dx.doi.org/10.1152/ajprenal.1997.273.1.f136.
Texto completoBerberich, I., G. L. Shu y E. A. Clark. "Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B." Journal of Immunology 153, n.º 10 (15 de noviembre de 1994): 4357–66. http://dx.doi.org/10.4049/jimmunol.153.10.4357.
Texto completoLalmanach-Girard, A. C., T. C. Chiles, D. C. Parker y T. L. Rothstein. "T cell-dependent induction of NF-kappa B in B cells." Journal of Experimental Medicine 177, n.º 4 (1 de abril de 1993): 1215–19. http://dx.doi.org/10.1084/jem.177.4.1215.
Texto completoSuzuki, Y. J., M. Mizuno y L. Packer. "Signal transduction for nuclear factor-kappa B activation. Proposed location of antioxidant-inhibitable step." Journal of Immunology 153, n.º 11 (1 de diciembre de 1994): 5008–15. http://dx.doi.org/10.4049/jimmunol.153.11.5008.
Texto completoDominguez, I., L. Sanz, F. Arenzana-Seisdedos, M. T. Diaz-Meco, J. L. Virelizier y J. Moscat. "Inhibition of protein kinase C zeta subspecies blocks the activation of an NF-kappa B-like activity in Xenopus laevis oocytes". Molecular and Cellular Biology 13, n.º 2 (febrero de 1993): 1290–95. http://dx.doi.org/10.1128/mcb.13.2.1290-1295.1993.
Texto completoDominguez, I., L. Sanz, F. Arenzana-Seisdedos, M. T. Diaz-Meco, J. L. Virelizier y J. Moscat. "Inhibition of protein kinase C zeta subspecies blocks the activation of an NF-kappa B-like activity in Xenopus laevis oocytes." Molecular and Cellular Biology 13, n.º 2 (febrero de 1993): 1290–95. http://dx.doi.org/10.1128/mcb.13.2.1290.
Texto completoSingh, Shareen y Thakur Gurjeet Singh. "Role of Nuclear Factor Kappa B (NF-κB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach". Current Neuropharmacology 18, n.º 10 (4 de noviembre de 2020): 918–35. http://dx.doi.org/10.2174/1570159x18666200207120949.
Texto completoLin, K. I., S. H. Lee, R. Narayanan, J. M. Baraban, J. M. Hardwick y R. R. Ratan. "Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B." Journal of Cell Biology 131, n.º 5 (1 de diciembre de 1995): 1149–61. http://dx.doi.org/10.1083/jcb.131.5.1149.
Texto completoBlackwell, T. S., T. R. Blackwell, E. P. Holden, B. W. Christman y J. W. Christman. "In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation." Journal of Immunology 157, n.º 4 (15 de agosto de 1996): 1630–37. http://dx.doi.org/10.4049/jimmunol.157.4.1630.
Texto completoLederer, J. A., J. S. Liou, S. Kim, N. Rice y A. H. Lichtman. "Regulation of NF-kappa B activation in T helper 1 and T helper 2 cells." Journal of Immunology 156, n.º 1 (1 de enero de 1996): 56–63. http://dx.doi.org/10.4049/jimmunol.156.1.56.
Texto completoXia, Longzheng, Shiming Tan, Yujuan Zhou, Jingguan Lin, Heran Wang, Linda Oyang, Yutong Tian et al. "Role of the NFκB-signaling pathway in cancer". OncoTargets and Therapy Volume 11 (abril de 2018): 2063–73. http://dx.doi.org/10.2147/ott.s161109.
Texto completoKichina, Julia V. "Transposons find a small RIP in NFκB pathway". Cell Cycle 7, n.º 14 (15 de julio de 2008): 2081–82. http://dx.doi.org/10.4161/cc.7.14.6598.
Texto completo王, 文静. "Regulation of NF-Kappa B Signaling Pathway by Hepatitis Viruses". Hans Journal of Biomedicine 10, n.º 03 (2020): 35–42. http://dx.doi.org/10.12677/hjbm.2020.103006.
Texto completoSalles, Angeles, Arturo Romano y Ramiro Freudenthal. "Synaptic NF-kappa B pathway in neuronal plasticity and memory". Journal of Physiology-Paris 108, n.º 4-6 (septiembre de 2014): 256–62. http://dx.doi.org/10.1016/j.jphysparis.2014.05.002.
Texto completoLaw, R. E., J. B. Stimmel, M. A. Damore, C. Carter, S. Clarke y R. Wall. "Lipopolysaccharide-induced NF-kappa B activation in mouse 70Z/3 pre-B lymphocytes is inhibited by mevinolin and 5'-methylthioadenosine: roles of protein isoprenylation and carboxyl methylation reactions". Molecular and Cellular Biology 12, n.º 1 (enero de 1992): 103–11. http://dx.doi.org/10.1128/mcb.12.1.103-111.1992.
Texto completoLaw, R. E., J. B. Stimmel, M. A. Damore, C. Carter, S. Clarke y R. Wall. "Lipopolysaccharide-induced NF-kappa B activation in mouse 70Z/3 pre-B lymphocytes is inhibited by mevinolin and 5'-methylthioadenosine: roles of protein isoprenylation and carboxyl methylation reactions." Molecular and Cellular Biology 12, n.º 1 (enero de 1992): 103–11. http://dx.doi.org/10.1128/mcb.12.1.103.
Texto completoMurray, Susan E., Alexander M. Rowe, Soumen Basak, Alexander Hoffmann y David C. Parker. "The alternative NF-kappa B pathway is essential for OX40-induced CD4 T cell differentiation and effector function (47.19)". Journal of Immunology 182, n.º 1_Supplement (1 de abril de 2009): 47.19. http://dx.doi.org/10.4049/jimmunol.182.supp.47.19.
Texto completoYokoo, T. y M. Kitamura. "Antioxidant PDTC induces stromelysin expression in mesangial cells via a tyrosine kinase-AP-1 pathway". American Journal of Physiology-Renal Physiology 270, n.º 5 (1 de mayo de 1996): F806—F811. http://dx.doi.org/10.1152/ajprenal.1996.270.5.f806.
Texto completoScheinman, R. I., A. A. Beg y A. S. Baldwin. "NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like molecule". Molecular and Cellular Biology 13, n.º 10 (octubre de 1993): 6089–101. http://dx.doi.org/10.1128/mcb.13.10.6089-6101.1993.
Texto completoScheinman, R. I., A. A. Beg y A. S. Baldwin. "NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like molecule." Molecular and Cellular Biology 13, n.º 10 (octubre de 1993): 6089–101. http://dx.doi.org/10.1128/mcb.13.10.6089.
Texto completoTao, Li, Xiaomeng Ren, Wenhui Zhai y Zheng Chen. "Progress and Prospects of Non-Canonical NF-κB Signaling Pathway in the Regulation of Liver Diseases". Molecules 27, n.º 13 (2 de julio de 2022): 4275. http://dx.doi.org/10.3390/molecules27134275.
Texto completoVan Antwerp, D. J. y I. M. Verma. "Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required." Molecular and Cellular Biology 16, n.º 11 (noviembre de 1996): 6037–45. http://dx.doi.org/10.1128/mcb.16.11.6037.
Texto completoReus, Joshua B., Emily A. Rex y Don B. Gammon. "How to Inhibit Nuclear Factor-Kappa B Signaling: Lessons from Poxviruses". Pathogens 11, n.º 9 (18 de septiembre de 2022): 1061. http://dx.doi.org/10.3390/pathogens11091061.
Texto completoSun, S., P. Ganchi, D. Ballard y W. Greene. "NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway". Science 259, n.º 5103 (26 de marzo de 1993): 1912–15. http://dx.doi.org/10.1126/science.8096091.
Texto completoKato, Motohiro, Masashi Sanada, Itaru Kato, Yasuharu Sato, Junko Takita, Ryoichiro Kawahata, Kengo Takeuchi et al. "Aberrations of Genes Regulating NF Kappa B Pathway in B-Cell Malignant Lymphoma." Blood 114, n.º 22 (20 de noviembre de 2009): 971. http://dx.doi.org/10.1182/blood.v114.22.971.971.
Texto completoShi, Xi, Shiwei Qiu, Wei Zhuang, Caiji Wang, Shili Zhang, Na Yuan, Fukang Yuan y Yuehua Qiao. "Follicle-stimulating hormone inhibits cervical cancer via NF-κB pathway". OncoTargets and Therapy Volume 11 (noviembre de 2018): 8107–15. http://dx.doi.org/10.2147/ott.s173339.
Texto completoJing, Nianshui y Xinnan Li. "Retraction on “Dihydromyricetin attenuates inflammation through TLR4/NF-kappa B pathway”". Open Medicine 16, n.º 1 (1 de enero de 2021): 1082. http://dx.doi.org/10.1515/med-2021-0331.
Texto completoShimada, Kana, Makio Saeki, Hiroshi Egusa, Sho Fukuyasu, Yoshiaki Yura, Kazuhiro Iwai y Yoshinori Kamisaki. "RPAP3 enhances cytotoxicity of doxorubicin by impairing NF-kappa B pathway". Biochemical and Biophysical Research Communications 404, n.º 4 (enero de 2011): 910–14. http://dx.doi.org/10.1016/j.bbrc.2010.12.071.
Texto completoYokoo, T. y M. Kitamura. "Dual regulation of IL-1 beta-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-kappa B and AP-1". American Journal of Physiology-Renal Physiology 270, n.º 1 (1 de enero de 1996): F123—F130. http://dx.doi.org/10.1152/ajprenal.1996.270.1.f123.
Texto completoGoebeler, M., J. Roth, E. B. Bröcker, C. Sorg y K. Schulze-Osthoff. "Activation of nuclear factor-kappa B and gene expression in human endothelial cells by the common haptens nickel and cobalt." Journal of Immunology 155, n.º 5 (1 de septiembre de 1995): 2459–67. http://dx.doi.org/10.4049/jimmunol.155.5.2459.
Texto completoMoriuchi, H., M. Moriuchi y A. S. Fauci. "Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection." Journal of Immunology 158, n.º 7 (1 de abril de 1997): 3483–91. http://dx.doi.org/10.4049/jimmunol.158.7.3483.
Texto completoHuang, Wei, Zheng Cao, Ye Wu, Zhenzhou Li, Li Li y Yantao Zhao. "Bone Marrow Mesenchymal Stem Cells (BMSCs) Promote Neuronal Cell Repair in Spinal Cord Injury by Regulating Toll-Like Receptor 4/Nuclear Factor-Kappa B Signaling Pathway". Journal of Biomaterials and Tissue Engineering 11, n.º 10 (1 de octubre de 2021): 2064–69. http://dx.doi.org/10.1166/jbt.2021.2791.
Texto completoZuo, Jiahang, Hongbo Ye, He Lin, Guangfu Lv, Yuchen Wang, Xiaowei Huang y Zhe Lin. "Study on the Antipyretic Mechanism of Baihu Decoction: Network Pharmacology Prediction and Experimental Verification". Journal of Biobased Materials and Bioenergy 15, n.º 3 (1 de junio de 2021): 334–41. http://dx.doi.org/10.1166/jbmb.2021.2070.
Texto completoDas, Subhankar, Ramu Periyasamy y Kailash N. Pandey. "Activation of IKK/NF-κB provokes renal inflammatory responses in guanylyl cyclase/natriuretic peptide receptor-A gene-knockout mice". Physiological Genomics 44, n.º 7 (1 de abril de 2012): 430–42. http://dx.doi.org/10.1152/physiolgenomics.00147.2011.
Texto completoVenkataraman, L., S. J. Burakoff y R. Sen. "FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells." Journal of Experimental Medicine 181, n.º 3 (1 de marzo de 1995): 1091–99. http://dx.doi.org/10.1084/jem.181.3.1091.
Texto completoAlleboina, Satyanarayana, Thomas Wong, Madhu V. Singh y Ayotunde O. Dokun. "Inhibition of protein kinase C beta phosphorylation activates nuclear factor-kappa B and improves postischemic recovery in type 1 diabetes". Experimental Biology and Medicine 245, n.º 9 (23 de abril de 2020): 785–96. http://dx.doi.org/10.1177/1535370220920832.
Texto completoHan, Y. P., T. L. Tuan, H. Wu, M. Hughes y W. L. Garner. "TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP". Journal of Cell Science 114, n.º 1 (1 de enero de 2001): 131–39. http://dx.doi.org/10.1242/jcs.114.1.131.
Texto completoWu, Hongjin, Weiwei Dai, Libo Wang, Jie Zhang y Chenglong Wang. "Effects of Reducing the South and Reinforcing the North Method on Inflammatory Injury Induced by Hyperlipidemia". Evidence-Based Complementary and Alternative Medicine 2021 (20 de septiembre de 2021): 1–18. http://dx.doi.org/10.1155/2021/1860508.
Texto completoGeng, Hao, Wenhao Guo, Lei Feng, Dongdong Xie, Liangkuan Bi, Yi Wang, Tao Zhang, Zhaofeng Liang y Dexin Yu. "Diallyl trisulfide inhibited tobacco smoke-mediated bladder EMT and cancer stem cell marker expression via the NF-κB pathway in vivo". Journal of International Medical Research 49, n.º 3 (marzo de 2021): 030006052199290. http://dx.doi.org/10.1177/0300060521992900.
Texto completoLagunas, Vilma Maldonado y Jorge Meléndez-Zajgla. "Nuclear Factor-kappa B as a Resistance Factor to Platinum-Based Antineoplasic Drugs". Metal-Based Drugs 2008 (8 de abril de 2008): 1–6. http://dx.doi.org/10.1155/2008/576104.
Texto completoAnisowicz, A., M. Messineo, S. W. Lee y R. Sager. "An NF-kappa B-like transcription factor mediates IL-1/TNF-alpha induction of gro in human fibroblasts." Journal of Immunology 147, n.º 2 (15 de julio de 1991): 520–27. http://dx.doi.org/10.4049/jimmunol.147.2.520.
Texto completoOrthner, CL, GM Rodgers y LA Fitzgerald. "Pyrrolidine dithiocarbamate abrogates tissue factor (TF) expression by endothelial cells: evidence implicating nuclear factor-kappa B in TF induction by diverse agonists". Blood 86, n.º 2 (15 de julio de 1995): 436–43. http://dx.doi.org/10.1182/blood.v86.2.436.bloodjournal862436.
Texto completoPuvvada, Soham D., Jason Smith, Cassandra L. Jacobs y Sandeep Dave. "Selective IKKβ Inhibition of the NF-Kappab Pathway Is An Effective Therapeutic Strategy In Lymphomas". Blood 116, n.º 21 (19 de noviembre de 2010): 1849. http://dx.doi.org/10.1182/blood.v116.21.1849.1849.
Texto completoLiu, Ganlu, Jingfeng Lin, Lina Zhang, Qiang Gao, Zhenyi Wang, Ze Chang, Ying Gao, Dayong Ma y Zhenyun Han. "Uncovering the Mechanism of the Xingnaojing Injection against Ischemic Stroke Using a Combined Network Pharmacology Approach and Gut Microbiota Analysis". Evidence-Based Complementary and Alternative Medicine 2022 (20 de mayo de 2022): 1–35. http://dx.doi.org/10.1155/2022/5886698.
Texto completoZhou, Li, Zhe-Zhi Deng, Hai-Yan Li, Nan Jiang, Zhi-Sheng Wei, Ming-Fan Hong, Xiao-Dang Chen et al. "TRIM31 promotes glioma proliferation and invasion through activating NF-κB pathway". OncoTargets and Therapy Volume 12 (marzo de 2019): 2289–97. http://dx.doi.org/10.2147/ott.s183625.
Texto completoShu, Chang, Jun Chen, Meiyan Lv, Yiyuan Xi, Jujia Zheng y Xiangwei Xu. "Plumbagin relieves rheumatoid arthritis through nuclear factor kappa-B (NF-κB) pathway". Bioengineered 13, n.º 5 (2 de mayo de 2022): 13632–42. http://dx.doi.org/10.1080/21655979.2022.2081756.
Texto completoDai, Yu-Qiao, Dao-Zhong Jin, Xing-Zu Zhu y De-Liang Lei. "Triptolide inhibits COX-2 expression via NF-kappa B pathway in astrocytes". Neuroscience Research 55, n.º 2 (junio de 2006): 154–60. http://dx.doi.org/10.1016/j.neures.2006.02.013.
Texto completoLabouba, I., S. Mehairi, M. Latour, A. Mes-Masson y F. Saad. "Implication of the alternative NF-kappa B pathway in prostate cancer progression." Journal of Clinical Oncology 28, n.º 15_suppl (20 de mayo de 2010): 10592. http://dx.doi.org/10.1200/jco.2010.28.15_suppl.10592.
Texto completoWan, Ying, Heather L. Francis, Nan Wu, Kelly McDaniel, Tianhao Zhou, Julie Venter, Haibo Bai, Shannon Glaser, Gianfranco Alpini y Fanyin Meng. "653 microRNA-34a Regulates Alcoholic Hepatitis Through SIRT1/NF-kappa;B Pathway". Gastroenterology 150, n.º 4 (abril de 2016): S1043. http://dx.doi.org/10.1016/s0016-5085(16)33525-9.
Texto completo